2ᴺᴰ World Symposium on Pulmonary Hypertension Evian, France 1998

Supported by industry with co-sponsorship of WHO

it was prompted by a remarkable growth of the knowledge about every aspect of this disease

17 Members Scientific Organizing Committee (S. Rich & L. J. Rubin, co-chairs) and 85 Members Task Forces

Main advances:

Better understanding of the mechainsms of the disease

A clinical classification was proposed

Identication of effective therapies (Calcium antagonists, Epoprostenol, Lung Transplantation)